Acquisition of a Next-Generation Sequencer

This tender concerns the acquisition of a Next-Generation Sequencer (NGS) for the Centre Hospitalier de l'Université de Montréal (CHUM), an entity operating under Santé Québec. The procurement falls under the category of G21, which covers medical supplies and pharmaceuticals, specifically including DNA sequence analyzers. The procurement method selected is a negotiated contract, justified by Article 13, Paragraph 4°, which allows for direct negotiation when a public tender is deemed not to serve the public interest. This implies that Santé Québec has assessed the specific needs and circumstances and determined that a direct award is the most appropriate and beneficial approach for the public interest in this instance. The acquisition of an NGS is a critical investment for advanced medical research and diagnostics, enabling high-throughput sequencing of DNA and RNA. Such technology is fundamental for genomic studies, personalized medicine, disease diagnosis, and the development of targeted therapies. The CHUM, as a leading university hospital center, will leverage this new equipment to enhance its capabilities in cutting-edge biomedical research and clinical applications, ultimately aiming to improve patient care and outcomes through advanced genomic insights. The specific rationale for bypassing a public tender suggests unique technical requirements, specialized expertise, or a time-sensitive need that a standard bidding process might not adequately address.

This is a supplies contract in the health and medical services and information and communication technology sectors, with a focus on Medical Equipment, Laboratory and Data Analytics. Located in Canada, North America, this opportunity is open to firms and consortiums.

Published through Quebec SEAO, a national government procurement portal. Public procurement tenders follow the country's national bidding regulations and may have specific eligibility and documentation requirements for the supply of goods in the health and medical services sector. Supply contracts typically require bidders to demonstrate product compliance with technical specifications, delivery capacity, and relevant certifications. This contract has already been awarded. The information is published for transparency and market intelligence purposes.